authors
- Pogosova, Nana
- Bosch, Jackie
- Bhatt, Deepak L
- Fox, Keith AA
- Connolly, Stuart J
- Alings, Marco
- Verhamme, Peter
- Muehlhofer, Eva
- Shestakovska, Olga
- Yusuf, Salim
- Eikelboom, John
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 21, 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Aspirin (MeSH)
- Atherosclerosis (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Therapy, Combination (MeSH)
- Factor Xa Inhibitors (MeSH)
- Humans (MeSH)
- Peripheral Arterial Disease (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Rivaroxaban (MeSH)
- Venous Thromboembolism (MeSH)
published in
- Circulation Journal